Archive · 1 Jul 2025
India's Pharma Exports Surge to $4.9 Billion in April-May
Imagine India sells a lot of medicine to other countries.
In the first two months of this year, they sold almost $5 billion worth!
That's a big jump from last year.
Most of what they sell is medicine that doctors prescribe.
They're also selling more vaccines than before, which helps people around the world.
The US buys the most medicine from India.
This growth is happening because India is working hard to improve how they make medicine and how they get it to other countries.
India's pharmaceutical exports reached $4.9 billion in April-May of FY26.
This marks a 7.38% expansion compared to the same period last year.
Drug formulations and biologicals dominate the export category.
Vaccine exports saw a 13.64% increase, reaching $190.13 million.
The US is the top destination, with $1.7 billion in exports.
- Who
- India's pharmaceutical industry and Pharmexcil.
- What
- India's pharmaceutical exports reached $4.9 billion in April-May.
- When
- April-May of FY26.
- Where
- Exports are from India.
- Why
- Growth is attributed to rising global demand, streamlined approvals, and strategic partnerships.
- Total Exports (April-May FY26)
- $4.9 billion
- Growth Rate
- 7.38%
- Dominant Category
- Drug formulations and biologicals
- Vaccine Export Increase
- 13.64%
- Vaccine Exports Value
- $190.13 million
- Top Destination
- United States
- US Exports
- $1.7 billion